The risk factors for upgrading the Gleason score in PCa were studied and the existing literature shows that the length of the biopsy cores together with parameters like PSA, tumoral volume, and the percentage of the tumor on the biopsy cores can predict upgrading [10]. This evidence concerns the gene KLK3 and neoplasm.